VivoSeq
Cardiovascular

Cardiovascular Prevention

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cardiovascular Prevention is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed4 · 80%
Recruiting1 · 20%

Clinical Trials

Trial Activity

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
Completed·TThe George Institute·Phase 4·NCT00263393·3,712 enrolled
Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Completed·FFundación Centro Nacional de Investigaciones Cardiovasculares Carlos III·Phase 3·NCT01321255·2,118 enrolled
Cardiovascular Prevention for Persons With HIV
Completed·HHennepin Healthcare Research Institute·N/A·NCT00982189·37 enrolled
The Cardiovascular Prevention Program
Recruiting·MMaria Cecilia Hospital·N/A·NCT06362538·150 enrolled
The YOU-Fish Study: Exploring the Effects of Fish Consumption and Omega 3 Supplementation on the Vascular Health of Young Adults
Completed·UUniversity of Ulster·Preclinical·NCT06729229·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)